Advanced BioScience Laboratories, Inc. (ABL) has opened its new research and manufacturing facility following the expansion of its vaccine and biotherapeutic product development capabilities at its new headquarters in Rockville, MD. The company has invested more than $12 million in the facility expansion, which will serve as headquarters for ABL’s administration, lab services, and cGMP manufacturing, with room for future expansion. Dr. Thomas VanCott, president and chief executive officer of ABL, said, “ABL has expanded to meet increasing demand for high quality product development and manufacturing services in the local and international biopharmaceutical communities. We will continue to work closely with our clients to accelerate the advance of discoveries to clinical testing by leveraging 50 years of scientific expertise combined with the benefits of this new facility.” – See more here.